Trademark: 90980667
Word
TPU PHARMA
Status
Registered
Status Code
700
Status Date
Tuesday, January 9, 2024
Serial Number
90980667
Registration Number
7270464
Registration Date
Tuesday, January 9, 2024
Mark Type
4000
Filing Date
Monday, October 12, 2020
Published for Opposition
Tuesday, March 23, 2021

Trademark Owner History
Teikoku Pharma USA, Inc. - Original Registrant

Classifications
5 Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics
"PHARMA"

Trademark Events
Jan 9, 2024
Notice Of Registration Confirmation Emailed
Jan 9, 2024
Registered-Principal Register
Dec 8, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 7, 2023
Allowed Principal Register - Sou Accepted
Dec 1, 2023
Statement Of Use Processing Complete
Nov 14, 2023
Use Amendment Filed
Dec 1, 2023
Divisional Processing Complete
Nov 29, 2023
Divisional Request Received
Nov 14, 2023
Teas Request To Divide Received
Nov 27, 2023
Case Assigned To Intent To Use Paralegal
Nov 14, 2023
Teas Statement Of Use Received
May 11, 2023
Notice Of Approval Of Extension Request E-Mailed
May 9, 2023
Sou Extension 4 Granted
May 9, 2023
Sou Extension 4 Filed
May 9, 2023
Sou Teas Extension Received
Nov 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 15, 2022
Sou Extension 3 Granted
Nov 15, 2022
Sou Extension 3 Filed
Nov 15, 2022
Sou Teas Extension Received
May 18, 2022
Notice Of Approval Of Extension Request E-Mailed
May 16, 2022
Sou Extension 2 Granted
May 16, 2022
Sou Extension 2 Filed
May 16, 2022
Sou Teas Extension Received
Nov 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 11, 2021
Sou Extension 1 Granted
Nov 11, 2021
Sou Extension 1 Filed
Nov 11, 2021
Sou Teas Extension Received
May 18, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 23, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 23, 2021
Published For Opposition
Mar 3, 2021
Notification Of Notice Of Publication E-Mailed
Feb 16, 2021
Approved For Pub - Principal Register
Feb 16, 2021
Examiner's Amendment Entered
Feb 16, 2021
Notification Of Examiners Amendment E-Mailed
Feb 16, 2021
Examiners Amendment E-Mailed
Feb 16, 2021
Examiners Amendment -Written
Feb 6, 2021
Previous Allowance Count Withdrawn
Feb 2, 2021
Withdrawn From Pub - Og Review Query
Jan 15, 2021
Approved For Pub - Principal Register
Jan 14, 2021
Examiner's Amendment Entered
Jan 14, 2021
Assigned To Lie
Jan 13, 2021
Notification Of Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment -Written
Jan 8, 2021
Assigned To Examiner
Nov 28, 2020
New Application Office Supplied Data Entered
Oct 15, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24